WallachBeth announced the completion of the purchase and sale of 2,000,000 shares of common stock of ABVC BioPharma, Inc. (Nasdaq: ABVC), and warrants to …
Latest News
WallachBeth Capital Announces Purchase and Sale of LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) $5.8 Million Registered Direct Offering Priced At-The-Market
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that LIXTE Biotechnology Holdings, Inc. …
Andy McOrmond Joined CNBC’s ETF Edge Halftime Report
Andy McOrmond, Managing Director, joined CNBC’s ETF Edge Halftime Report to discuss inflation, commodities and Chinese …
[Read more...] about Andy McOrmond Joined CNBC’s ETF Edge Halftime Report